Insitro
Claim this toolLeveraging machine learning and data to accelerate drug discovery and development.
Paid plans only Visit Website Paid Visit Website
Tracked since 2026
The Bottom Line
- Price
- Paid plans only. Compare plans
Key facts
- Uses machine learning and data to accelerate drug discovery.
- Integrates cellular and human clinical data for therapeutic insights.
- Developing a pipeline in metabolism, oncology, and neuroscience.
Pros
- Accelerates drug discovery and development process
- Leverages advanced machine learning for biological insights
- Integrates diverse data sources for comprehensive understanding
- Focuses on critical disease areas like oncology and neuroscience
- Fosters a collaborative, interdisciplinary team culture
Cons
- No information on specific drug candidates or clinical trial progress available on this page
- Requires significant data and computational resources
- Complexity of biological systems can still pose challenges
What is Insitro?
Insitro is a drug discovery and development company that uses machine learning (ML) and large-scale data to redefine how new medicines are created. The company integrates in vitro cellular data from its labs with human clinical data to build a robust ML-driven platform. This platform is designed to decode biological complexities, identify therapeutic insights, and accelerate the development of new drugs across various diseases.
Insitro's approach aims to bring better drugs to patients faster by precisely identifying interventions. They are building a pipeline of wholly-owned and partnered therapeutic programs focusing on metabolism, oncology, and neuroscience. The company fosters a unique culture where diverse experts, including life scientists, data scientists, engineers, and drug hunters, collaborate to drive scientific breakthroughs in drug discovery.
Key Features
- Machine learning-driven drug discovery platform
- Integration of in vitro cellular data
- Integration of human clinical data
- Pipeline development in metabolism, oncology, and neuroscience
- Identification of therapeutic insights and interventions
Pricing
Paid
Insitro offers paid plans. Visit their website for current pricing details.
Insitro by the numbers
| Metric | Insitro | Peer median | Position (1 is best) |
|---|---|---|---|
| Free plan | No | 16 of 28 have one | n/a |
| Listed as an alternative to | 2 tools | 2 | #11 of 28 (joint) |
Listed as an alternative to: #11 on 2026-10-16 to #11 on 2026-11-02 (rank among 28 tools, 1 is best).
Each position is counted among the tools that have data for that row, as noted under it. All Research & Science data · How we compute this. Advertising and placement fees are not inputs to any position.
Cite this: Toolradar, “Insitro by the numbers”, Nov 2026.
Reviews
$99 Free with your review
Write a review Review Insitro, get a free AI guide
Share your experience and we will send you Improve Your Thinking Patterns Using ChatGPT, free.
Best Insitro Alternatives
Top alternatives based on features, pricing, and user needs.
Still deciding?
Most buyers shortlist 2 or 3 tools before committing. Pull a side-by-side comparison or browse the full alternatives shortlist below.
Explore More
Insitro FAQ
How does Insitro accelerate drug discovery?
Insitro accelerates drug discovery by using machine learning and large-scale data to identify therapeutic insights. It integrates in vitro cellular data from its labs with human clinical data to build a robust ML-driven platform, aiming to bring better drugs to patients faster.
Which teams benefit most from Insitro's approach?
Teams involved in life sciences, data science, engineering, and drug discovery can benefit from Insitro's approach. The company fosters a collaborative culture where diverse experts work together to drive scientific breakthroughs in drug discovery.
How does Insitro compare to Starget Pharma?
Insitro differentiates itself from companies like Starget Pharma by leveraging advanced machine learning and integrating diverse data sources for a comprehensive understanding of biological complexities. This approach aims to accelerate the drug discovery and development process across various diseases.
What kind of data does Insitro utilize in its platform?
Insitro's platform integrates in vitro cellular data from its own labs with human clinical data. This combination allows for a comprehensive understanding of biological complexities and the identification of therapeutic insights.
What are the primary disease areas Insitro focuses on?
Insitro focuses on building a pipeline of therapeutic programs in critical disease areas. These include metabolism, oncology, and neuroscience, addressing significant unmet medical needs.
Does Insitro include a free tier for its services?
Insitro is a paid product and does not offer a permanently free tier for its services. Its advanced machine learning and data integration capabilities are part of its comprehensive drug discovery platform.
What are the main trade-offs when using Insitro's platform?
A main trade-off is the significant data and computational resources required for its operation. Additionally, the inherent complexity of biological systems can still pose challenges despite its advanced machine learning approach.
Source: insitro.com